Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614469 · ClinicalTrials.gov registry record · Phase 1
A Food-Drug Interaction Study of Serum Urate After Oral Inosine
A Phase 1 study of Healthy, sponsored by Michael Alan Schwarzschild.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02614469: Completed Phase 1 study of Healthy, sponsored by Michael Alan Schwarzschild.
NCT02614469 is a Phase 1 study of Healthy that has completed, run by Michael Alan Schwarzschild. The registered enrollment target is 18 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02614469, a Phase 1 study of Healthy, has completed, sponsored by Michael Alan Schwarzschild.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effects of food on the amount of urate in the body after a single oral dose of inosine.
Conditions Studied
Interventions
- DRUG Inosine
Study Locations (1)
Indiana
- Covance Clinical Research Unit Inc. - Evansville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02614469
The ClinicalTrials.gov registry entry for NCT02614469 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Michael Alan Schwarzschild, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Inosine is the first listed.
NCT02614469 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT02614469 about?
NCT02614469 is a clinical study titled "A Food-Drug Interaction Study of Serum Urate After Oral Inosine". The purpose of this study is to assess the effects of food on the amount of urate in the body after a single oral dose of inosine.
What is the current status of trial NCT02614469?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2015-03. Estimated completion is 2016-05.
What conditions does trial NCT02614469 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT02614469?
The interventions under investigation include: Inosine (DRUG).
Who is sponsoring clinical trial NCT02614469?
This trial is sponsored by Michael Alan Schwarzschild, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02614469 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
RECRUITING · Phase 1
-
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
RECRUITING · Phase 1
-
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
RECRUITING · Phase 1
-
A Study of V118E in Healthy Participants (V118E-003)
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.